Paul V Maier is Director of Ambrx Biopharma Inc.. Currently has a direct ownership of 85,000 shares of AMAM, which is worth approximately $2.38 Million. The most recent transaction as insider was on Jun 07, 2023, when has been sold 85,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85K
0% 3M change
0% 12M change
Total Value Held $2.38 Million

PAUL V MAIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
BUY
Grant, award, or other acquisition
-
85,000 Added 50.0%
85,000 Ordinary Shares

Also insider at

ETON
Eton Pharmaceuticals, Inc. Healthcare
ISCO
International Stem Cell CORP Healthcare
AMAM
Ambrx Biopharma, Inc.
PVM

Paul V Maier

Director
Deer Park, IL

Track Institutional and Insider Activities on AMAM

Follow Ambrx Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMAM shares.

Notify only if
Any

Insider Trading

Get notified when an Ambrx Biopharma Inc. insider buys or sells AMAM shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Ambrx Biopharma Inc.

Track Activities on AMAM